InvestSMART

Osteopore Limited (ASX: OSX) - Announcements

- Current share price for OSX : $0.005

ASX company news and announcements for Osteopore Limited (OSX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Osteopore Limited (OSX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Osteopore Limited (OSX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Osteopore Limited (OSX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Application for quotation of securities - OSX 23 Jul 2026 6:52PM $0.005 $0.005 risen by 11.11%
$3 First OSX custom orthopaedic implant delivered to Hainan 14 Jul 2026 8:43AM $0.005 $0.005 fallen by 0%
$3 OSX & Zimmer gain craniofacial market access to Saudi Arabia 7 Jul 2026 8:34AM $0.005 $0.005 fallen by 0%
$3 OSX completes co-development project for neurosurgical guide 2 Jul 2026 8:24AM $0.005 $0.005 fallen by 0%
$3 First patient treated in OSX-PAH jaw reconstruction trial 30 Jun 2026 8:52AM $0.004 $0.005 risen by 25%
$3 First 2 patients treated in QCH cleft lip clinical trial 29 Jun 2026 8:26AM $0.005 $0.005 risen by 11.11%
$3 QCH cleft lip clinical study patient recruitment completed 26 Jun 2026 8:17AM $0.004 $0.005 risen by 25%
$3 OSX neuro products approved in a major centre in Thailand 24 Jun 2026 8:52AM $0.005 $0.005 risen by 11.11%
$3 Cleansing Notice 23 Jun 2026 9:02AM $0.005 $0.005 risen by 11.11%
$3 Notification regarding unquoted securities - OSX 23 Jun 2026 8:57AM $0.005 $0.005 risen by 11.11%
$3 Further Drawdown of T2 of the Redeemable Convertible Notes 23 Jun 2026 8:51AM $0.005 $0.005 risen by 11.11%
$3 First OSX custom orthopaedic implant completed in Hong Kong 22 Jun 2026 8:41AM $0.004 $0.005 risen by 25%
$3 OSX & DKSH Malaysia dental launch First products delivered 17 Jun 2026 8:51AM $0.005 $0.005 risen by 11.11%
$3 Notification of cessation of securities - OSX 15 Jun 2026 6:41PM $0.005 $0.005 fallen by 0%
$3 Becoming a substantial holder 10 Jun 2026 6:12PM $0.005 $0.005 fallen by 0%
$3 Ceasing to be a substantial holder 9 Jun 2026 7:02PM $0.006 $0.005 fallen by 16.67%
$3 Application for quotation of securities - OSX 9 Jun 2026 9:03AM $0.006 $0.005 fallen by 16.67%
$3 OSX & QCH launch trial for nasoalveolar augment in children 2 Jun 2026 9:08AM $0.006 $0.005 fallen by 16.67%
$3 Change in substantial holding 28 May 2026 6:45PM $0.007 $0.005 fallen by 28.57%
$3 OSX secures Hainan FDA approval for orthopaedic devices 26 May 2026 8:59AM $0.006 $0.005 fallen by 16.67%
$3 Results of Annual General Meeting 21 May 2026 2:10PM $0.007 $0.005 fallen by 28.57%
$3 OSX orthopaedic products gain Malaysian market access rights 15 May 2026 8:46AM $0.007 $0.005 fallen by 28.57%
$3 Cleansing Notice 12 May 2026 1:09PM $0.007 $0.005 fallen by 28.57%
$3 Application for quotation of securities - OSX 12 May 2026 1:05PM $0.007 $0.005 fallen by 28.57%
$3 Becoming a substantial holder 4 May 2026 1:08PM $0.006 $0.005 fallen by 16.67%

1 - 25 of 509 results

Page 1 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.